Cargando…

Identification of potential antivirals against SARS-CoV-2 using virtual screening method

SARS-CoV-2 has triggered a major epidemic among people around the world, and it is the newest in the sequence to become prevalent among other infectious diseases. The drug repurposing concept has been utilized effectively for numerous viral infections. Considering the situation and the urgency, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, Mohammad Rejaur, Banik, Anik, Chowdhury, Ishtiak Malique, Sajib, Emran Hossain, Sarkar, Sanchita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874919/ https://www.ncbi.nlm.nih.gov/pubmed/33594342 http://dx.doi.org/10.1016/j.imu.2021.100531

Ejemplares similares

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach
por: Azim, Kazi Faizul, et al.
Publicado: (2020)

Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10
por: Zhao, Huilin, et al.
Publicado: (2022)

Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)
por: Khodadadi, Ehsaneh, et al.
Publicado: (2020)

Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease
por: Chowdhury, Kamrul Hasan, et al.
Publicado: (2020)

Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
por: Sakib, Md Minhas Hossain, et al.
Publicado: (2021)

Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19)
por: El-Demerdash, Amr, et al.
Publicado: (2021)

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022)

Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
por: Mahmud, Shafi, et al.
Publicado: (2021)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Comprehensive genome based analysis of Vibrio parahaemolyticus for identifying novel drug and vaccine molecules: Subtractive proteomics and vaccinomics approach
por: Hasan, Mahmudul, et al.
Publicado: (2020)

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

Natural selection shapes the evolution of SARS-CoV-2 Omicron in Bangladesh
por: Habib, Mohammad Tanbir, et al.
Publicado: (2023)

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target
por: Qin, Bo, et al.
Publicado: (2023)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

SARS-CoV-2 replicon for high-throughput antiviral screening
por: Zhang, Qiu-Yan, et al.
Publicado: (2021)

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
por: Bojkova, Denisa, et al.
Publicado: (2023)

Ayurvedic metal nanoparticles could be novel antiviral agents against SARS-CoV-2
por: Sarkar, Prasanta Kumar, et al.
Publicado: (2021)

Identification of FDA Approved Antiviral Drugs for COVID-19 Treatment using Unbiased Virtual Screening
por: Greer, Rory, et al.
Publicado: (2021)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
por: Wang, Hu, et al.
Publicado: (2022)

Identification of inhibitors against SARS-CoV-2 variants of concern using virtual screening and metadynamics-based enhanced sampling
por: Mandal, Nabanita, et al.
Publicado: (2023)

Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach
por: Gupta, Yash, et al.
Publicado: (2021)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2
por: Abdizadeh, Rahman, et al.
Publicado: (2021)

Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection
por: Goswami, Soumik, et al.
Publicado: (2023)

In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2
por: Chakraborty, Rajkumar, et al.
Publicado: (2022)

Identification of natural compounds targeting SARS-CoV-2 Mpro by virtual screening and molecular dynamics simulations
por: Zhang, Chuanming, et al.
Publicado: (2022)

Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning
por: Kadioglu, Onat, et al.
Publicado: (2021)

Virtual Screening and Molecular Design of Potential SARS-COV-2 Inhibitors
por: Tinkov, O. V., et al.
Publicado: (2021)

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2
por: Liang, Hualou, et al.
Publicado: (2021)

Virtual screening of phytochemical compounds as potential inhibitors against SARS-CoV-2 infection
por: Kothandan, Ram, et al.
Publicado: (2021)

Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity
por: Hamdy, Rania, et al.
Publicado: (2021)

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020)

Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT
por: Lü, Xudong, et al.
Publicado: (2022)

Identification of high affinity and low molecular alternatives of boceprevir against SARS-CoV-2 main protease: A virtual screening approach
por: Borkotoky, Subhomoi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_re2001v24rcdvufjqonjc3k1os